文献速递生殖医学

胚胎活检样本DNA污染对PGT-A染色体分析准确性的影响

Investigating DNA contamination affecting embryo biopsy specimens taken for PGT-A: Incidence and impact on the accuracy of chromosomal analysis.
PubMed 文献 · Reprod Biomed Online · 2026-02-19

该回顾性研究分析了32家IVF诊所的57,292例PGT-A样本,发现0.45%(256/57,292)的滋养层活检样本存在DNA污染,且各诊所污染率差异显著(P < 0.0001)。在155例有第二次未污染样本结果的胚胎中,若未检出污染,44.5%(69/155)的染色体状态分类可能出错,提示污染与诊断错误风险相关。

要点

  • PGT-A滋养层活检样本DNA污染总体发生率为0.45%(256/57,292)。
  • 各诊所污染率差异显著,部分低于1/1000,部分高出10倍以上。
  • 未检出污染时,44.5%(69/155)的胚胎染色体分类可能错误。

核心结论

  • DNA污染影响每222例样本中约1例,并可导致染色体状态误判。
  • 污染率应作为提供PGT-A诊所的关键性能指标。

研究设计与样本

  • 回顾性研究,纳入32家IVF诊所的57,292例临床PGT-A样本。
  • 采用经验证的PGT-A方法,包含超过4000个单核苷酸多态性(SNP)的基因分型。

主要发现

  • 总体污染检出率为0.45%(256/57,292)的滋养层活检样本。
  • 各诊所污染率差异显著(P < 0.0001,卡方检验)。
  • 155例污染活检胚胎有第二次未污染样本结果,其中44.5%(69/155)若未检出污染可能发生染色体状态分类错误。

关键数值与推荐

  • 污染检出率0.45%(256/57,292)。
  • 部分诊所污染率低于1/1000,另一些诊所污染率高出10倍以上。
  • 未检出污染时潜在分类错误率44.5%(69/155)。

临床怎么用

  • 应使用能检测DNA污染的验证后PGT-A方法。
  • 将污染发生率作为诊所PGT-A质量的关键性能指标进行监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the prevalence of DNA contamination in embryo biopsy samples taken for preimplantation genetic testing for aneuploidy (PGT-A), and how often might contamination lead to incorrect interpretation of results? DESIGN: A retrospective study of 57,292 clinical PGT-A samples from 32 IVF clinics was carried out to determine the frequency of DNA contamination affecting trophectoderm biopsy specimens. Testing employed a highly validated and widely used PGT-A method, which includes genotyping of >4000 single-nucleotide polymorphisms. RESULTS: Validation experiments confirmed the ability of the method to detect DNA contamination reliably. Overall, contamination was detected in 0.45% (256/57,292) of trophectoderm biopsy specimens, but rates at individual clinics varied significantly (P < 0.0001, chi-squared test). In total, 155 embryos with a contaminated biopsy specimen had a result from a second (uncontaminated) sample. Comparison of the two biopsies revealed that errors in classification of chromosomal status could have occurred in 44.5% (69/155) of these embryos if contamination had not been detected. CONCLUSIONS: DNA contamination affected one in 222 samples. However, frequencies below one in 1000 were achieved in some clinics, while the incidence of contamination was more than 10 times higher at other clinics. Contamination was associated with a substantial risk of diagnostic error, potentially leading to the discard of viable embryos or the transfer of aneuploid embryos. Validated PGT-A methods, capable of detecting DNA contamination, should be used, and the incidence of contamination should be considered a key performance indicator for clinics offering PGT-A.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Clark G, Babariya D, Kilbee M, et al. Investigating DNA contamination affecting embryo biopsy specimens taken for PGT-A: Incidence and impact on the accuracy of chromosomal analysis. Reprod Biomed Online. 2026. PMID: 42167074. doi:10.1016/j.rbmo.2026.105637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。